DBEU - ETF AI Analysis
Top Page
Xtrackers MSCI Europe Hedged Equity ETF (DBEU)
Rating:63Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Geographic Diversification Across Europe
Holdings spread across major European markets like the UK, France, Germany, Switzerland, and others help reduce the impact of weakness in any single country.
Balanced Sector Mix
Exposure to a range of sectors, including financials, industrials, health care, and technology, provides a more balanced risk profile than focusing on just one industry.
Negative Factors
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees may be higher than some cheaper index ETFs and can slightly reduce long-term returns.
Mixed Performance Among Top Holdings
While some leading positions like ASML and Siemens have performed strongly, others such as SAP, Nestlé, and AstraZeneca have been weaker, creating uneven contribution to returns.
High Weight in Financials
A relatively large allocation to financial stocks increases the fund’s sensitivity to banking and interest-rate related risks in Europe.
DBEU vs. SPDR S&P 500 ETF (SPY)
AUM667.45M
RegionEurope
Expense Ratio0.45%
Beta0.63
IssuerXtrackers
Inception DateOct 01, 2013
Dividend Yield4.44%
Asset ClassEquity
Index TrackedMSCI Europe 100% Hedged to USD Net Variant
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume140,745
30 Day Avg. Volume62,689
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DBEU Summary
DBEU is an ETF that follows the MSCI Europe U.S. Dollar Hedged Index, giving you broad exposure to large and mid-sized companies across many European countries while trying to reduce the impact of currency swings between the euro and the U.S. dollar. It holds well-known names like Nestlé and AstraZeneca, along with many banks, industrial firms, and health care companies. Someone might invest in DBEU to diversify beyond the U.S. and tap into Europe’s long-term growth while limiting currency risk. A key risk is that European stock prices can still go up and down with the overall market and regional economies.
How much will it cost me?The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations.
What would affect this ETF?The DBEU ETF could benefit from positive economic growth in Europe, particularly in sectors like financials and industrials, which make up a significant portion of its holdings. Additionally, its currency hedging strategy provides protection against euro-to-dollar fluctuations, which can stabilize returns for U.S. investors. However, potential risks include economic slowdowns in Europe, regulatory changes affecting key industries, or geopolitical tensions that could impact the performance of its top holdings like ASML and Nestlé.
DBEU Top 10 Holdings
DBEU leans heavily on Europe’s healthcare and financial giants, with drugmakers like Novartis and AstraZeneca providing a steadier hand while Roche has been losing steam and weighing on returns. Big banks such as HSBC are also lagging, adding a bit of drag. On the brighter side, energy names like Shell and TotalEnergies are doing the heavy lifting, rising on stronger commodity sentiment. ASML sits at the crossroads of Europe’s tech story with mixed but generally supportive momentum. Overall, it’s a developed Europe play, not a global one.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.75% | $25.27M | €448.98B | 74.19% | 76 Outperform | |
| AstraZeneca | 2.12% | $14.26M | $285.44B | 20.00% | 80 Outperform | |
| Novartis AG | 2.09% | $14.09M | CHF221.00B | 16.50% | 80 Outperform | |
| Roche Holding AG | 2.05% | $13.77M | CHF242.59B | 12.65% | 73 Outperform | |
| HSBC Holdings | 1.93% | $12.96M | £203.18B | 33.43% | 80 Outperform | |
| Nestlé SA | 1.89% | $12.73M | CHF189.31B | -5.64% | 71 Outperform | |
| Shell (UK) | 1.82% | $12.28M | £188.72B | 23.10% | 73 Outperform | |
| SAP SE | 1.43% | $9.61M | €175.18B | -40.04% | 66 Neutral | |
| Siemens | 1.37% | $9.25M | €161.07B | -11.49% | 74 Outperform | |
| TotalEnergies SE | 1.18% | $7.94M | €162.56B | 30.49% | 78 Outperform |
DBEU Technical Analysis
Positive
―
Price Trends
49.57
Negative
48.63
Positive
46.71
Positive
Market Momentum
-0.35
Negative
53.98
Neutral
94.58
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.39, equal to the 50-day MA of 49.57, and equal to the 200-day MA of 46.71, indicating a neutral trend. The MACD of -0.35 indicates Negative momentum. The RSI at 53.98 is Neutral, neither overbought nor oversold. The STOCH value of 94.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DBEU.
DBEU Peer Comparison
Comparison Results
Performance Comparison
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
49.25
10.66
27.62%
VGK
Vanguard FTSE Europe ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
FEUZ
First Trust Eurozone AlphaDEX ETF
―
―
―
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents